DTCFF   $2.09  -0.95% Market Closed

Defence Therapeutics Inc
Total Cash 56.55K
totalCashPerShare 0.001
EBITDA -12.68M
Total Debt 1.75M
quickRatio 0.038
currentRatio 0.053
Total Revenue
debtToEquity
Revenue/Share
ROA -3.97297
ROE
grossProfits
freeCashflow 88.21K
operatingCashflow -4.29M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 20.35M
forwardPE
floatShares 43.03M
sharesOutstanding 45.54M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.05%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.079
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -13.19M
trailingEps -0.22%
forwardEps
enterpriseToEbitda -1.60
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Oct. 22, 2024, 12:42 a.m.